Community infections that require admission to the ICU;Infecciones comunitarias que requieren ingreso en UCI

Medicina Intensiva

Volumn 34, Issue 6, 2010, Pages 388-396

  Blanquer, J ^a   Sole Violan J ^b   Carvajal, J ^c   Lucena, F ^d  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^c Dermatology Section   (Spain)

^d HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

Encephalitis; Extended spectrum betalactamases; Meningitis; Polymerase chain reaction; Severe community acquired pneumonias; Urinary tract infections

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; BIOLOGICAL MARKER; CEFEPIME; CEFOTAXIME; CEFTIBUTEN; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLAVULANIC ACID; CLOXACILLIN; DOXYCYCLINE; ERTAPENEM; FOSFOMYCIN TROMETAMOL; GENTAMICIN; IMIPENEM; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TOBRAMYCIN; VANCOMYCIN;

ARTICLE; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID EXAMINATION; COMMUNICABLE DISEASE; COMMUNITY ACQUIRED PNEUMONIA; CYSTITIS; DISEASE SEVERITY; EARLY INTERVENTION; ENCEPHALITIS; ESCHERICHIA COLI; GRAM STAINING; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PYELONEPHRITIS; REAL TIME POLYMERASE CHAIN REACTION; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BACTERIOLOGICAL TECHNIQUES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENCEPHALITIS; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MENINGITIS; PNEUMONIA; URINARY TRACT INFECTIONS;

EID: 77955514394     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2010.03.003     Document Type: Article

References (36)

1. Donowitz G., Mandell G. Acute pneumonia. Principles and Practice of infectious Diseases 2005, 819-845. Elsevier Churchill Livingstone, Philadelphia. G. Mandell, J. Bennett, R. Dolin (Eds.).
2. Alvarez-Rocha A., Alós J.I., Blanquer J., Alvarez-Lerma F., Garau J., Guerrero A., et al. Guías para el manejo de la neumonía comunitaria del adulto que precisa ingreso en el hospital. Med Intensiva 2005, 29:21-62.
3. Bodí M., Rodríguez A., Solé-Violán J., Gilavert M.C., Garnacho J., Blanquer J., et al. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival. Clin Infect Dis 2005, 41:1709-1716.
4. Marcos M.A., Esperatti M., Torres A. Viral pneumonia. Curr Opin Infect Dis 2009, 22:143-147.
5. Mandell L.A., Wunderink R.G., Anzueto A., Bartlett J.G., Campbell G.D., Dean N.C., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44:S27-S72.
6. Charles P.G., Wolfe R., Whitby M., Fine M.J., Fuller A.J., Stirling R., et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 2008, 47:375-384.
7. Renaud B., Labarère J., Coma E., Santin A., Hayon J., Gurgui M., et al. Risk stratification of early admission to the intensive care unit of patients with no major criteria of severe community-acquired pneumonia: development of an international prediction rule. Crit Care 2009, 13:R54.
8. Menéndez R., Martínez R., Reyes S., Mensa J., Filella X., Marcos M.A., et al. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax 2009, 64:587-591.
9. Rello J., Rodríguez A., Lisboa T., Gallego M., Luján M., Wunderink R. PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia. Crit Care Med 2009, 37:456-462.
10. Blot S.I., Rodríguez A., Solé-VIolán J., Blanquer J., Almirall J., Rello J. Effects of delayed oxygenation assessment on time to antibiotic delivery and mortality in patients with severe community-acquired pneumonia. Crit Care Med 2007, 35:2509-2514.
11. Brito V., Niederman M.S. Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia. Curr Opin Infect Dis 2009, 22:316-325.
12. Lynch 3rd J.P., Zhanel G.G. Streptococcus pneumoniae: does antimicrobial resistance matter?. Semin Respir Crit Care Med 2009, 30:210-238.
13. Bassetti M., Nicco E., Mikulska M. Why is community-associated MRSA spreadind across the world and how will it change clinical practice?. Int J Antimicrob Agents 2009, 34:S15-S19.
14. Rodríguez A., Mendía A., Sirvent J.M., Barcenilla F., de la Torre-Prados M.V., Solé-Violán J., et al. Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock. Crit Care Med 2007, 35:1493-1498.
15. Olaechea P. Infecciones bacterianas en el paciente crítico: revisión de los estudios publicados entre 2006 y 2008. Med Intensiva 2009, 33:196-206.
16. Ochoa-Gondar O., Vila-Córcoles A., Ansa X., Rodríguez-Blanco T., Salsench E., de Diego C., et al. Effectiveness of pneumococcal vaccination in older adults with chronic respiratory diseases: results of the EVAN-65 study. Vaccine 2008, 26:1955-1962.
17. Honda H., Warren D.K. Central nervous system infections: meningitis and brain abscess. Infect Dis Clin North Am 2009, 23:609-623.
18. Ziai W.C., Lewin III J.J. Update in the diagnosis and management of central nervous system infections. Neurol Clin 2008, 26:427-468.
19. van de Beek D., de Gans J., Tunkel A.R., Widjdicks E.F. Community-acquired bacterial meningitis in adults. N Engl J Med 2006, 354:44-53.
20. Tunkel A.R., Hartman B.J., Kaplan S.L., Kaufman B.A., Roos K.L., Scheld W.M., et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004, 39:1267-1284.
21. Deutch S., Pedersen L.N., Podenphant L., Olesen R., Schmidt M.B., Moller J.K., et al. Broad-range real time PCR and DNA sequencing for the diagnosis of bacterial meningitis. Scand J Infect Dis 2006, 38:27-35.
22. Van de Beek D., de Gans J., Mc Intyre P., Prasad K. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2007, CD004405.
23. Ricard J.D., Wolff M., Lacherade J.C., Mourvillier B., Hidri N., Barnaud G., et al. Levels of vancomycin in cerebrospinal fluid of adults patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study. Clin Infect Dis 2007, 44:250-255.
24. Camporota L., Wyncoll D. Practical aspects of treatment with drotrecogin alfa (activated). Crit Care 2007, 11(Suppl 5):S7.
25. Vincent J.L., Nadel S., Kutsogiannis D.J., Gibney R.T., Yan S.B., Wyss V.L., et al. Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies. Crit Care 2005, 9:R331-R343.
26. Lindvall P., Ahlm C., Ericsson M., Gothefors L., Naredi S., Koskinen L.O. Reducing intracranial pressure may increase survival among patients with bacterial meningitis. Clin Infect Dis 2004, 38:384-390.
27. Grande P.O., Myhre E.B., Nordstrom C.H., Schliamser S. Treatment of intracranial hypertension and aspects on lumbar dural puncture in severe bacterial meningitis. Acta Anaesthesiol Scand 2002, 46:264-270.
28. Tunkel A.R., Glaser C.A., Bloch K.C., Sejvar J.J., Marra C.M., Roos K.L., et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008, 47:303-327.
29. Grupo de Trabajo de Enfermedades Infecciosas de la Sociedad Española de Medicina Intensiva Crítica y Unidades Coronarias. Estudio Nacional de Vigilancia de Infección Nosocomial en Servicios de Medicina Intensiva (ENVIN). Informe anual 2008.
30. Blanco J., Muriel-Bombín A., Sagredo V., Taboada F., Gandía F., Tamayo L., et al. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care 2008, 12:R158. Grupo de Estudios y Análisis en Cuidados Intensivos.
31. Laupland K.B., Baghaw S.M., Gregson D.B., Kirkpatrick A.W., Ross T., Church D.L. Intensive care unti acquired urinary tract infections in a regional critical care system. Crit Care 2005, 9:R60-R65.
32. Sánchez Pulgarín I., Kessler Saiz P., Odriozola Grijalva M. Cistitis Enfisematosa. An Med Interna 2006, 23:602-603.
33. Terradas R., Grau S., Knobel H., Álvarez-Lerma F., Riu M., Salvadó M. Bacteriemia comunitaria tratada o identificada de forma ambulatoria tras el alta de un Servicio de Urgencias. Med Clin (Barc) 2007, 129:652-654.
34. Andreu A., Alós J.I., Gobernado M., Marco F., Rosa M., García-Rodríguez J.A. Etiología y sensibilidad a los antimicrobianos de los uropatógenos causantes de la infección urinaria baja adquirida en la comunidad. Estudio nacional multicéntrico. Enferm Infecc Microbiol Clin 2005, 23(1):4-9. Grupo Cooperativo Español para el Estudio de la Sensibilidad Antimicrobiana de los Patógenos Urinarios.
35. Rodríguez-Baño J., Alcalá J., Cisneros J., Grill F., Oliver A., Horcajada J., et al. Community infections caused by extended-spectrum Β-lactamase-producing Escherichia coli. Arch Intern Med 2008, 168:1897-1902.
36. Caro M., Hernando S., Carrero P., García S. Estudio de multirresistencia antibiótica de Escherichia coli en urocultivos. Med Clin (Barc) 2007, 129:409-411.